NFKB1 and neoplasm: We showed that expression of a dominant NF-κB inhibitor in airway epithelium markedly reduced lung tumorigenesis in mice [9], while over-expression of an NF-κB activator in IKTA mice enhanced carcinogen-induced lung tumors and was able to function as a tumor promoter in the presence of an initiating agent (mutagen) [10].